Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

KLF14 Inhibitors

KLF14 (Kruppel-like factor 14) is a transcription factor implicated in the regulation of a wide array of genetic pathways, especially those involved in lipid metabolism, glucose homeostasis, and adipogenesis. It functions as a master regulator by modulating the expression of genes involved in these metabolic processes. KLF14 is notable for its role in controlling the activity of several genes in adipose tissue, influencing metabolic traits in humans. The protein exerts its regulatory function through binding to GC-rich sequences in the promoter regions of target genes, thereby affecting their transcriptional activity. Its activity is crucial for the proper maintenance of metabolic balance and cellular differentiation processes. Given its pivotal role in metabolic regulation, KLF14 is a significant focus of research concerning the molecular mechanisms underlying metabolic disorders. The inhibition of KLF14 involves mechanisms that reduce its transcriptional regulatory activity, thereby impacting the expression of genes under its control. This can occur through direct interactions with the KLF14 protein that prevent its binding to DNA, or through upstream regulatory pathways that modulate its expression or activity. For example, post-translational modifications such as phosphorylation, ubiquitination, or sumoylation can alter KLF14's ability to interact with DNA or with other regulatory proteins, effectively modulating its function. Additionally, the competitive binding of other transcription factors or co-repressors can inhibit KLF14's activity by either blocking its access to target gene promoters or by recruiting chromatin remodeling complexes that alter the accessibility of these regions. The precise regulation of KLF14 is crucial for its role in metabolic processes, and its inhibition can lead to significant alterations in gene expression patterns, affecting the metabolic state of cells and tissues. Understanding the mechanisms of KLF14 inhibition provides insights into the complex regulatory networks that maintain metabolic homeostasis and highlights the intricate balance of transcriptional control mechanisms in cellular physiology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

Bromodomain inhibitor that affects the reading of acetylation marks, thereby influencing transcription factor accessibility and could impact KLF14 activity indirectly.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that could influence pathways upstream of KLF14, altering its transcriptional activity.

Chaetocin

28097-03-2sc-200893
200 µg
$120.00
5
(1)

Disrupts hypoxia-inducible factor (HIF) pathways, which may intersect with KLF14's role in metabolic regulation.

GW 9662

22978-25-2sc-202641
5 mg
$68.00
30
(2)

PPARγ antagonist that can modulate adipogenic pathways, likely influencing KLF14 function given its role in adipose tissue distribution.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that could interfere with stress and inflammatory signaling pathways, possibly affecting KLF14's regulatory roles.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Another PI3K inhibitor that could modify signaling cascades related to KLF14's activity.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

ROCK inhibitor that may alter cytoskeletal organization and related signaling, potentially impacting KLF14's cellular context.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor that alters cellular growth pathways, which could have downstream effects on KLF14's transcriptional control.

Wnt-C59

1243243-89-1sc-475634
sc-475634A
sc-475634B
5 mg
10 mg
50 mg
$210.00
$320.00
$1250.00
1
(0)

Wnt pathway inhibitor that could modify cellular differentiation pathways intersecting with KLF14's regulatory scope.